|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Sales | |||||
| Cost of sales | |||||
| Gross profit (loss) | |||||
| General and administrative | |||||
| Sales and marketing | |||||
| Management compensation | |||||
| Professional fees | |||||
| Professional fees - related party | |||||
| Professional fees (including share-based payments of $144,000 and $nil, respectively) | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Other income | |||||
| Interest income | |||||
| Total other income and (expense) | |||||
| Interest expense - related party | |||||
| Accretion of discount on convertible note | |||||
| Gain on partial sale of investment | |||||
| Gain (Loss) on Extinguishment of Debt | |||||
| Total other income (expense), net | |||||
| Loss before provision for income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Net loss | |||||
| Net loss per common share - basic and diluted | |||||
| Weighted average common shares outstanding - basic and diluted | |||||
| Basic net loss per common share | |||||
| Diluted net loss per common share | |||||
| Weighted average common shares outstanding - basic | |||||
| Weighted average common shares outstanding - diluted | |||||
Loading...